Bio-Techne Corp (TECH) financial statements (2021 and earlier)

Company profile

Business Address 614 MCKINLEY PL N E
MINNEAPOLIS, MN 55413
State of Incorp. MN
Fiscal Year End June 30
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
3/31/2020
Q3
12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments166169147156110100101
Cash and cash equivalents166169147156110100101
Receivables128123123117112123137
Inventory, net of allowances, customer advances and progress billings107106103100959191
Inventory107106103100959191
Other current assets24262414142018
Other undisclosed current assets1171181241051345965
Total current assets:542542521492465392413
Noncurrent Assets
Operating lease, right-of-use asset687071747677 
Property, plant and equipment196192177165164157154
Intangible assets, net (including goodwill)1,2511,2391,2451,2561,2841,2941,312
Goodwill747732728726734730733
Intangible assets, net (excluding goodwill)504508517530550563579
Other noncurrent assets11101412966
Total noncurrent assets:1,5261,5111,5071,5071,5331,5331,472
TOTAL ASSETS:2,0682,0532,0281,9991,9981,9251,884
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities74646663614977
Accounts payable24272320191416
Accrued liabilities1413910111126
Employee-related liabilities32223123191829
Taxes payable422101376
Deferred revenue131313141299
Debt13131313222213
Business combination, contingent consideration, liability56661083
Other liabilities3      
Other undisclosed current liabilities10101010   
Total current liabilities:11810510710510588102
Noncurrent Liabilities
Long-term debt and lease obligation, including:219311344407370474493
Operating lease, liability646667697273 
Other undisclosed long-term debt and lease obligation155245277338299401493
Liabilities, other than long-term debt137132128126232834
Deferred income tax liabilities10510110196   
Other liabilities26302728212225
Business combination, contingent consideration, liability6002359
Other undisclosed noncurrent liabilities64      
Total noncurrent liabilities:419443472533394501527
Total liabilities:537548579638499589629
Stockholders' equity
Stockholders' equity attributable to parent1,5221,4391,3811,2911,3231,1741,166
Common stock0000000
Additional paid in capital481449421382363334317
Accumulated other comprehensive loss(64)(83)(97)(103)(78)(92)(84)
Retained earnings1,1051,0731,0571,0131,039931932
Stockholders' equity attributable to noncontrolling interest9      
Total stockholders' equity:1,5311,4391,3811,2911,3231,1741,166
Other undisclosed liabilities and equity 66676917616190
TOTAL LIABILITIES AND EQUITY:2,0682,0532,0281,9991,9981,9251,884

Income statement (P&L) ($ in millions)

12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
3/31/2020
Q3
12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
Revenues224204176195185183192
Cost of revenue
(Cost of Goods and Services Sold)
(73)(66)(63)(65)(64)(65)(63)
Gross profit:151138113130121118128
Operating expenses(100)(89)(74)(82)(84)(85)(85)
Operating income:51493948373343
Nonoperating income (expense)5(10)22(1)113(16)(20)
Other nonoperating income (expense)9(5)273118(10)(15)
Interest and debt expense(4)(4)(5)(4)(5)(5)(6)
Income from continuing operations before equity method investments, income taxes:533557421451317
Other undisclosed income from continuing operations before income taxes4454556
Income from continuing operations before income taxes:563962471501823
Income tax expense(10)(6)(3)(10)(31)(3)(6)
Net income:463359361201416
Net income attributable to noncontrolling interest0      
Other undisclosed net loss attributable to parent      (0)
Net income attributable to parent:463359361201416
Undistributed earnings (loss) allocated to participating securities, basic(0)(0)(0)(0)(0)(0)(0)
Net income available to common stockholders, diluted:463359361191416

Comprehensive Income ($ in millions)

12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
3/31/2020
Q3
12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
Net income:463359361201416
Other comprehensive income19      
Comprehensive income:653359361201416
Comprehensive income, net of tax, attributable to noncontrolling interest0      
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 146(25)13(8)(4)
Comprehensive income, net of tax, attributable to parent:65476511133613

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: